INDEX
Page numbers in italics denote a figure, table,
or box.
A
Abdominal actinomycosis, 109
Abdominal infection, 107
Abdominal pain, 162
ABRS. See Acute bacterial rhinosinusitis
(ABRS)
Abscesses, 218
Acid-fast bacilli (AFB), 250
Acne
age variations, 521–523, 523
benzoyl peroxide, 527
causes and differential diagnosis, 520,
520–521
clinical features, 521–523, 523
evaluation, 524–525
long-term monitoring, 534
management, 525–526, 525–527
mild, 531–532
moderate, 532
oral antibiotic, 530
oral retinoid, 530–531
overview, 519
pediatric treatment algorithm for, 525–526
phenotypes and systemic disease, 523–524,
524
severe, 533
suboptimal treatment responses, 533
topical antibiotic, 527
topical retinoid, 527
treatments, 528–529
types and targeted treatment options, 534
Acneiform rashes, 607
Acrodermatitis, 607
Actinomycosis, 107, 109
medical therapy for, 115
Active immunization, 419
Acute bacterial rhinosinusitis (ABRS)
adjunctive therapy in patients with, 31–36
algorithm for, 33
antibiotic choices for, 32
antimicrobials, 32–34
causes and differential diagnosis, 29, 29–30
clinical features, 30–31
definitions, 28
evaluation, 31
first-line empiric therapy for, 34–35
long-term monitoring and implications, 36
management, 31–36, 32–33
microbiology, 28–29
overview, 27–28
second-line empiric therapy for, 36
Acute disseminated candidiasis, 437
Acute encephalitis, 394
Acute flaccid paralysis (AFP), 303, 308
Acute glomerulonephritis, 151
Acute hemorrhagic conjunctivitis, 306
Acute osteomyelitis, 74, 222
Acute otitis media
antibiotic recommendations/preferences,
21–26, 22
antimicrobial treatment decisions, 22–23
causes and differential diagnosis, 16, 16–17
clinical features, 18, 18–20, 19–20
definitions, 18
expected pathogens in, 16
follow-up, 26
laboratory investigations, 20–21
long-term monitoring and implications, 27
management, 21–26, 22
otorrhea with pressure-equalizing tube in
place, 25–26
pain, 21–22
prevention, 26–27
prophylactic antibiotics, 26
radiology, 21
social strategies, 27
specific antibiotic choices, 23–25
surgical approach, 26
vaccines, 26–27
Acute otitis media and mastoiditis, 147
Acute phase proteins, 87
Acute primary EBV infection, 320
Acute primary infection, signs and symptoms
of, 325
Acute rubella encephalitis, 372
Acute schistosomiasis (Katayama fever), 503
Acute severe, ABRS, 31
Acute toxoplasmosis, diagnosis of, 513, 514
Acute watery diarrhea, 130
Acyclovir
encephalitis, 293, 296, 297, 298
Epstein-Barr virus, 321
meningitis, 60, 63
varicella-zoster virus, 416
Adenovirus, 314, 314, 399–400, 401
Adjunctive corticosteroids, 62
Adjunctive surgical interventions, 432
Adjunctive therapies, 552–553
Adverse effects, 74
Aeromonas hydrophila, 49, 52
AFB. See Acid-fast bacilli (AFB)
Previous Page Next Page